药学相关英文论文怎么写

Cardiovascular and cerebrovascular diseases have become a high incidence, Xuesaitong injection in a hospital clinical treatment of cardiovascular and cerebrovascular diseases one of the main drug. Xuesaitong major components for the March 7 total saponin, a Huoxue casual addicts, Tongmai active effectiveness. Pharmacological studies confirmed that the materials have increased coronary blood flow, the expansion of blood vessels and reduce arterial blood pressure, reducing myocardial oxygen consumption, inhibit platelet aggregation, reduce blood viscosity role. For cerebral vascular diseases, including acute ischemic cerebrovascular disease, sequelae of cerebral vascular hemorrhage, paralysis and diseases such as retinal vein occlusion treatment. By studying Xuesaitong injection pharmacological properties and clinical applications, adverse reactions and control measures, in order Xuesaitong injection provide a basis for rational drug use for clinical drug safety guarantee. Key words: Xuesaitong injection, clinical applications, adverse reactions, prevention measures

The afferent disease in brain in heart has become the high outbreak, the blood fills the 通 injects the liquid is an afferent paroxysm in brain in heart in clinical treatment in hospital to use the one of the medicines blood fills main composition in通 as 3 7 total soap 苷 , have the live blood spread the 癖 , the vein of 通 limbers up the medicine reason research confirms this article has the to build up hat vein blood measureses and extend blood vessel, lower the artery blood pressure and lower the myocardial consume oxygen measure, repress blood platelets come together, lower the blood glues a for the fat ⅰ in笠 in� in鲅 in艹 in� in full circle in⒛ in ? in疾 in管 in血 in脑 in性 in血 in缺 in性 in急 in括 in包 in afferent disease in brain the ⑻ drive 炯笆 oil �ぞ猜鲎枞�燃膊〉闹瘟啤 Pass the blood that study the 通 fill the medicine injects liquid reason medicine, clinical application, bad reaction and prevention and cure measure etc. aspect, fill for the blood the reasonable that 通 inject liquid use the medicine the offering according to, for clinical use the medicine safety offering guarantee.或Abstract: cardiovascular and cerebrovascular diseases have become a high incidence, Xuesaitong injection in a hospital clinical treatment of cardiovascular and cerebrovascular diseases one of the main drugs. Xuesaitong major components for the PNS, with Huoxue casual addiction, Tongmai active effectiveness. Pharmacological studies confirm that the goods have increased coronary blood flow, the expansion of blood vessels, lowering blood pressure, reducing myocardial oxygen consumption, inhibiting platelet aggregation, lower blood viscosity role. For cerebral vascular diseases, including acute ischemic cerebrovascular disease, cerebral vascular hemorrhage after-effects, paralysis and diseases such as retinal vein occlusion treatment. Through research Xuesaitong injection of pharmacological properties, clinical applications, adverse reactions and control measures, in order Xuesaitong injection provide a basis for rational drug use for clinical drug safety guarantee. Key words: Xuesaitong injection, clinical application, adverse reactions, control measures或Cardiovascular and cerebrovascular diseases have become a high incidence, Xuesaitong injection in a hospital clinical treatment of cardiovascular and cerebrovascular diseases one of the main drugs. Xuesaitong major components for the PNS, with Huoxue casual addiction, Tongmai active effectiveness. Pharmacological studies confirm that the goods have increased coronary blood flow, the expansion of blood vessels, lowering blood pressure, reducing myocardial oxygen consumption, inhibiting platelet aggregation, lower blood viscosity role. For cerebral vascular diseases, including acute ischemic cerebrovascular disease, cerebral vascular hemorrhage after-effects, paralysis and diseases such as retinal vein occlusion treatment. Through research Xuesaitong injection of pharmacological properties, clinical applications, adverse reactions and control measures, in order Xuesaitong injection provide a basis for rational drug use for clinical drug safety guarantee.

摘要目标为了研究吉西他滨的药效学和药物动力学的作用， 在未做过化疗的IIIB期或IV期非小细胞型肺癌的病人中，在第一天(不确定是什么意思，但估计是day 1 的意思）和第5天给予吉西他滨和顺铂，第5天只单独给予吉西他滨。方法在每一个周期中，第一天和第5天吉西他滨的剂量是1250毫克每平方米，30分钟静脉输液完。第一天在给予吉西他滨后再给与顺铂75毫克每平方米，3小时静脉输液完。每3周一次。两次输液中间间隔一小时。这种治疗的临床反应和毒性被密切观察了。另外，吉西他滨的血浆含量和代谢物在不同时间点上的值在第一个周期中被侦察了。药物动力学的软件PKS被用于分析吉西他滨的药物动力学计数和它的代谢产物。结果这次研究中一共有28位病患。中间年龄54岁（从27－75岁），大部分病患处于良好状态。27位病患接受了2次或更多的周期治疗。总体临床反应率为％。总体来说，平均存活时间为13个月。肿瘤发展平均时间为个月，一年存活率是％。毒性可承受。主要毒性是骨髓抑制。的病患有3/4级血液毒性，％有非血液型毒性，比如胃肠道反应。吉西他滨的血浆含量和代谢产物的药物动力学计数在给药前和给药后是不同的。吉西他滨的代谢产物最小值 ± μg/mL是在静脉输入吉西他滨之前和不给与吉西他滨的时候。结论这个治疗方法对于非化疗的已发展的非小细胞型肺癌患者是可承受并有作用的。在第一天和第五天给与吉西他滨后，吉西他滨的血浆含量和代谢产物的药物动力学计数没有任何不同和在输液前相比。而且在第5天给药前吉西他滨的代谢产物达到最小值。

Abstract: Heart blood vessel of brain disease has become the high morbidity, the thrombosis passes the inoculation fluid is one of hospital clinical treatment heart blood vessel of brain disease main thrombosis passes the principal constituent is 37 total soap glucoside, has invigorates the blood to disperse the hobby, promotes blood circulation the detachable pharmacology research confirmed this has the enhancement crown arteries blood stream quantity, the expansion blood vessel, reduces the arterial blood pressure, reduces the cardiac muscle oxygen consumption capacity, the suppression blood platelet accumulation, reduces the blood viscosity in the blood vessel of brain disease including the acute anemic blood vessel of brain disease, the blood vessel of brain hemorrhage sequela, the paralysis and disease and so on retina vein blocking treatments. Passes the inoculation fluid through the research thrombosis the pharmacology property of a medicine, the clinical practice, responded not good and aspects and so on preventing and controlling measure, pass the inoculation fluid for the thrombosis the reasonable medication to provide the basis, provides the guarantee safely for the clinical medication. Key word: The thrombosis passes the inoculation fluid, the clinical practice, responded not good, preventing and controlling measure